Implant jab could solve the misery of back pain

May 19, 2011

(PhysOrg.com) -- University of Manchester scientists have developed a biomaterial implant which could finally bring treatment, in the form of a jab, for chronic back pain.

Chronic is a major problem for society – behind only headaches as the most common neurological ailment – and is frequently caused by degeneration of the intervertebral disc.

Researchers have worked for many years to find a way of repairing the wear and tear on the lower back.

Now, in results published in the journal Soft Matter, they have discovered how to permanently replace the workings of the invertebral disc.

It is estimated that back affects 80% of people at some point in their lives. In the United States it is the most common cause of job-related disability, a leading contributor to people missing work.

The University of Manchester cross-faculty team have been working with microgel particles, which are swellable nanoscopic polymer particles, for a number of years.

Previously, they have demonstrated that an injectable fluid of these particles could transform into a gel that restored the mechanical properties of damaged model intervertebral discs.

Lead researcher Dr Brian Saunders, of the School of Materials, and his team have now succeeded in linking the microgel particles together to form injectable durable, elastic gels capable of sustaining large permanent changes in shape without breaking.

These improved injectable gels have much better mechanical properties than the first generation and should now display the necessary long-term durability required for an implanted device.

In this study the researchers – who include PhD student Amir Milani and Dr Ruixue Liu – have achieved an important milestone for producing injectable gels for minimally-invasive repair of IVD degeneration.

Dr Saunders said: ““Our team has made a breakthrough through innovative materials design that brings the prospect of an injectable gel for treating degeneration of the intervertebral disc a step closer.

Professor Tony Freemont, Head of Research in the School of Biomedicine, and co-author on the paper, added:
“Degeneration of the intervertebral disc results in which costs the country billions of pounds per annum and causes untold misery for sufferers and their families.

“We have been working for 25 years to identify methods for treating degeneration of the intervertebral disc.”

More information: Doubly crosslinked pH-responsive microgels prepared by particle inter-penetration: swelling and mechanical properties, by Ruixue Liu, Amir H. Milani, Tony J. Freemont and Brian R. Saunders, Soft Matter.

Related Stories

Recommended for you

Want to win at sports? Take a cue from these mighty mice

July 20, 2017
As student athletes hit training fields this summer to gain the competitive edge, a new study shows how the experiences of a tiny mouse can put them on the path to winning.

A sodium surprise: Engineers find unexpected result during cardiac research

July 20, 2017
Irregular heartbeat—or arrhythmia—can have sudden and often fatal consequences. A biomedical engineering team at Washington University in St. Louis examining molecular behavior in cardiac tissue recently made a surprising ...

Engineered liver tissue expands after transplant

July 19, 2017
Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available.

Lunatic Fringe gene plays key role in the renewable brain

July 19, 2017
The discovery that the brain can generate new cells - about 700 new neurons each day - has triggered investigations to uncover how this process is regulated. Researchers at Baylor College of Medicine and Jan and Dan Duncan ...

'Smart' robot technology could give stroke rehab a boost

July 19, 2017
Scientists say they have developed a "smart" robotic harness that might make it easier for people to learn to walk again after a stroke or spinal cord injury.

New animal models for hepatitis C could pave the way for a vaccine

July 19, 2017
They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.